Glucotrack (GCTK) Cash & Equivalents Growth (3y) (2013 - 2025)
Glucotrack (GCTK) Cash & Equivalents Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -2.17% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -25.69% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 93.87% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -16.21% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 7.45% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 8.39% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 6.48% |
| 10 | Glucotrack | 4.26 | -7.38 Mn | - | 47.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 47.26% |
| Mar 31, 2025 | 23.86% |
| Dec 31, 2024 | -2.51% |
| Sep 30, 2024 | -63.30% |
| Jun 30, 2024 | -72.79% |
| Mar 31, 2024 | -44.77% |
| Dec 31, 2023 | -22.96% |
| Sep 30, 2023 | -13.67% |
| Jun 30, 2023 | -8.66% |
| Mar 31, 2023 | -56.78% |
| Dec 31, 2022 | 76.71% |
| Sep 30, 2022 | 38.41% |
| Jun 30, 2022 | 19.19% |
| Mar 31, 2022 | 439.04% |
| Dec 31, 2021 | 296.73% |
| Sep 30, 2021 | 95.15% |
| Jun 30, 2021 | 669.14% |
| Mar 31, 2021 | 204.62% |
| Dec 31, 2020 | 467.37% |
| Sep 30, 2020 | 185.16% |